Obesity

Efficacy and Safety of Anti‐Obesity Medications for Weight Loss Maintenance in Adults With Overweight or Obesity: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials

Diabetes Obes MetabPublished Systematic review and meta-analysis of randomised trials

Pooled result · Body weightResult — go to the resultWMD −8.68 kg 95% CI −13.25 to −4.11

Authors' conclusion

AOM therapy during the weight-maintenance phase can help prevent weight regain, provide further reductions in body weight and improve cardiometabolic risk factors in adults with overweight or obesity. Gastrointestinal adverse events were more common with AOMs, whereas serious adverse events were not significantly increased.

Study context

Population
Adults with overweight or obesity after initial weight loss achieved through lifestyle, dietary, surgical or pharmacological interventions
Participants
4,915 adults12 randomised controlled trials (RCTs)
Comparison
Anti-obesity medications vs placebo during weight-maintenance phase
Outcome
Body weight
Follow-up
Weight-maintenance phase
Methodological detailsfixed-effect or random-effects models, Cochrane RoB 2, GRADE
  • Fixed-effect or random-effects models
  • Cochrane RoB 2
  • GRADE

Pooled result

As reported in the abstract

WMD

−8.68 kg

95% CI −13.25 to −4.11

AOMsvs Placebo
WMD −8.68 kg (95% CI −13.25 to −4.11)

Further pooled results

OutcomeWMD (cm) (95% CI)
Waist circumference−7.16 (−10.34 to −3.98)
OutcomeWMD (kg/m²) (95% CI)
BMI−3.58 (−5.69 to −1.46)

Cardiometabolic outcomes

Additional benefits for TG, total cholesterol, LDL-C, systolic and diastolic blood pressure

Quality of life

Available quality-of-life measures favoured AOM treatment

Safety

Gastrointestinal adverse events more common with anti-obesity medications (AOMs)
Serious adverse events not significantly increased
Neuropsychiatric adverse events generally comparable between groups

Original publication

Efficacy and Safety of Anti‐Obesity Medications for Weight Loss Maintenance in Adults With Overweight or Obesity: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials. Diabetes Obes Metab. Published 9 July 2026. doi:10.1111/dom.71083

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.